Efficacy of Axitinib After Nivolumab Failure in Metastatic Renal Cell Carcinoma

Background/Aim: Whether molecular-targeted therapy, particularly axitinib, is effective after failure of immune checkpoint inhibitors in metastatic renal cell carcinoma (mRCC) remains unclear. Here, we evaluated the therapeutic effect of axitinib as a third-line therapy following second-line nivolum...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:In Vivo
Main Authors: ISHIHARA, HIROKI, TAKAGI, TOSHIO, KONDO, TSUNENORI, FUKUDA, HIRONORI, TACHIBANA, HIDEKAZU, YOSHIDA, KAZUHIKO, IIZUKA, JUNPEI, OKUMI, MASAYOSHI, ISHIDA, HIDEKI, TANABE, KAZUNARI
Formato: Artigo
Idioma:Inglês
Publicado: International Institute of Anticancer Research 2020
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7279840/
https://ncbi.nlm.nih.gov/pubmed/32354960
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.11943
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares